Imprimis Acquires Proprietary Compounded Conscious Sedation Formulations
Imprimis Pharmaceuticals has acquired the rights to novel proprietary sedation and analgesia/anesthesia formulations that are administered sublingually to block pain and sedate patients undergoing ocular and other surgical procedures, according to a news release. After completing its intellectual property diligence process ...